SCHEMBL4224401

SCHEMBL4224401

CCOC(=O)c1nc(Nc2ccc(O)cc2)nc(Nc2ccccc2OC)c1[N+](=O)[O-]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.52
GSK3B P49841 2/20 0.52
POLB P06746 2/20 0.52
NR1I2 O75469 1/20 0.52
AHR P35869 1/20 0.52
CDK5 Q00535 1/20 0.52
CDK5R1 Q15078 1/20 0.52
MAPT P10636 10/20 0.51
TDP1 Q9NUW8 2/20 0.51
AURKA O14965 3/20 0.50
IGF1R P08069 1/20 0.49
KMT2A Q03164 5/20 0.47
GAA P10253 2/20 0.47
RAD52 P43351 1/20 0.47
BLM P54132 1/20 0.47
ATM Q13315 1/20 0.47
MEN1 O00255 4/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1748903 0.91 GSK3A (0.53) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL4223368 0.91 GSK3A (0.51) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL1751472 0.86 IGF1R (0.53) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL1751684 0.85 GSK3A (0.51) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL4052739 0.81 IGF1R (0.51) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL4227109 0.81 IGF1R (0.51) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL4052746 0.81 IGF1R (0.51) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL656365 0.80 POLB (0.51) POLBCDK5CDK5R1MAPTTDP1
SCHEMBL4566417 0.76 GSK3A (0.45) GSK3AGSK3BPOLBNR1I2AHR
SCHEMBL656643 0.75 MAPT (0.50) POLBMAPTTDP1IGF1RKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed